ALTIMMUNE, INC. Operating Leases, Future Minimum Payments, Due in Four Years
ALTIMMUNE, INC. (ALT) had Operating Leases, Future Minimum Payments, Due in Four Years of $405.90 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2019-04-01
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $405.90K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $429.13K.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $356.90K.
- 2012-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $846.20K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $405.90K 10-K · filed 2019-04-01 |
| 2017-12-31 | $429.13K 10-K · filed 2018-04-02 |
| 2013-12-31 | $356.90K 10-K · filed 2014-03-11 |
| 2012-12-31 | $846.20K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |